The fold-change analysis with respect to the analyzed benign tumors, determined that the carcinomas showed an average of 18 times more (18 fold-changes) expression of the wt-TP53 gene than the wt-TP53 gene in benign tumors (p = 0.04, Figure 7A). The gene discussed is TP53; the disease is benign neoplasm.